Shukra Pharmaceuticals Ltd.
| BSE: 524632 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE551C01028 |
| BSE 00:00 | 12 Apr | 48.60 |
1.50 (3.18%) |
OPEN
54.00 |
HIGH
56.50 |
LOW
46.00 |
| NSE 05:30 | 01 Jan | Shukra Pharmaceuticals Ltd |
| OPEN | 54.00 |
| PREVIOUS CLOSE | 47.10 |
| VOLUME | 1895 |
| 52-Week high | 56.95 |
| 52-Week low | 24.65 |
| P/E | |
| Mkt Cap.(Rs cr) | 8 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Shukra Pharmaceuticals Ltd. (SHUKRAPHARMA) - Net Sales
Market Cap
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
| Aurobindo Pharma | 916.15 | -27.50 | -2.91 | 13266.48 |
| Cipla | 903.00 | 20.70 | 2.35 | 12659.15 |
| Sun Pharma.Inds. | 619.15 | -17.80 | -2.79 | 12531.93 |
| Dr Reddy's Labs | 4989.20 | 229.70 | 4.83 | 11850.40 |
| Lupin | 1045.75 | -33.85 | -3.14 | 11025.66 |
| Apollo Hospitals | 3011.90 | -121.40 | -3.87 | 9794.50 |
| Glenmark Pharma. | 498.35 | -31.25 | -5.90 | 6712.63 |
| Alkem Lab | 2744.70 | -87.55 | -3.09 | 6677.08 |
| Cadila Health. | 499.95 | -14.60 | -2.84 | 6347.40 |
| Torrent Pharma. | 2555.65 | -17.75 | -0.69 | 6168.44 |
| Divi's Lab. | 3783.40 | 32.25 | 0.86 | 5310.57 |
| Ipca Labs. | 2153.75 | 68.65 | 3.29 | 4337.82 |
| Piramal Enterp. | 1629.20 | -180.35 | -9.97 | 4219.19 |
| Alembic Pharma | 957.80 | -52.85 | -5.23 | 4132.55 |
| Abbott India | 15058.80 | -187.00 | -1.23 | 4093.14 |
| Glaxosmi. Pharma | 1454.30 | 8.50 | 0.59 | 3224.68 |
| Jubilant Pharmo | 729.60 | -6.85 | -0.93 | 3139.90 |
| Sanofi India | 8097.85 | -129.40 | -1.57 | 2901.10 |
| Laurus Labs | 416.20 | -5.55 | -1.32 | 2797.34 |
| Gland Pharma | 2595.70 | 65.70 | 2.60 | 2633.24 |
Quick Links for Shukra Pharmaceuticals:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
